Hepatitis C Virus Prevention
Research from Abbott Laboratories broadens understanding of hepatitis C virus prevention
Published in Hepatitis Weekly, March 12th, 2007
Scientists discuss in "Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro" new findings in hepatitis C virus. "The combinations of Abbott Hepatitis C virus (HCV) polymerase A-782759 with either Boehringer Ingelheim HCV NS3 protease inhibitor BILN-2061 or interferon (IFN) displayed additive to synergistic relationships over a range of concentrations of two-drug combination. Treatment of HCV replicon with A-782759, IFN or BILN-2061 for about 16 days resulted in dramatic reductions in HCV RNA (5.1, 3.0 and 3.9 log10 RNA copies, respectively)," scientists writing in the journal Antiviral Research report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-03-12)
More Articles from Hepatitis Weekly
- Cancer Vaccines
Dynavax Initiates Phase I Trial of Hepatitis B Therapy - Cancer Vaccines
Dynavax Provides 2007 Financial Outlook - Hepatitis
Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results - Hepatitis B Virus
SEBIVO (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B - Hepatitis C Virus
Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C - Hepatitis C Virus
Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C Genotypes 2 and 3 - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
